The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
Abstract
HLA-DR is a class II cell surface glycoprotein of the human histocompatibility complex usually expressed on the surface of cells that are simultaneously presenting foreign antigen to T-lymphocytes. Using immunohistochemical procedures with two specific monoclonal antibodies to HLA-DR, HLA-DR-positive reactive microglia were found in gray matter throughout the cortex of postmortem brains of patients with senile dementia of the Alzheimer type (SDAT) and were particularly concentrated in the areas of senile plaque formation. Double immunostaining with antibodies to glial fibrillary acidic protein (GFAP) showed that the HLA-DR-positive cells were different from the reactive astrocytes although the occasional positively staining giant astrocyte was also seen. Small numbers of resting microglia were HLA-DR-positive in white matter of both normal and SDAT brains. The SDAT cases also had reduced cortical choline acetyltransferase (ChAT) levels. In the 11 brains studied, the number of hippocampal HLA-DR-positive cells was positively correlated with the numbers of plaques and negatively correlated with average cortical ChAT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AD is accompanied by activation of microglia and astrocytes1,2 that affects the clearance and production of Aβ42,3,4 development and propagation of tau pathology,5 exacerbates neurodegeneration, and influences disease progression and severity.6,7”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [1]
In the citing paper
“Reactive gliosis and neural inflammation are hallmarks of AD4,122–125.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [122]
In the citing paper
“Microglia in AD have long been known to acquire what is typically considered a “reactive” morphology, with short, thick, and poorly ramified processes [67–69].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [69]
Citations
Cites
Handbook of Histopathological and Histochemical Techniques
(1974) · Elsevier eBooks · doi:10.1016/c2013-0-04011-x · Cited by 508
THE DETAILED DISTRIBUTION OF MHC CLASS II ANTIGENS IN NORMAL HUMAN ORGANS
Daar, A. S., Fuggle, S., Fabre, J. W., Ting, A., & Morris, P. J. (1984) · Transplantation · doi:10.1097/00007890-198409000-00019 · Cited by 432
Lampson, L. A., & Hickey, W. F. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4054 · Cited by 230
Interferon-γ induces the expression of H-2 and Ia antigens on brain cells
Wong, G. H., Bartlett, P. F., Clark‐Lewis, I., McKimm‐Breschkin, J. L., & Schrader, J. W. (1984) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(84)80026-0 · Cited by 181
Distribution of choline acetyltransferase-containing neurons of the hypothalamus
Tago, H., McGeer, P. L., Bruce, G., & Hersh, L. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90268-x · Cited by 142
Self-citationMizukawa, K., McGeer, P. L., Tago, H., Peng, J. H., McGeer, E. G., & Kimura, H. (1986) · Brain Research · doi:10.1016/0006-8993(86)90253-2 · Cited by 120
Self-citationDemonstration of HLA-DR antigens in normal human brain.
de Tribolet, N., Hamou, M., Mach, J. P., Carrel, S., & Schreyer, M. (1984) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.4.417 · Cited by 57
Immunofluorescence studies of the monocytes in the injured rat brain
Tsuchihashi, Y., Kitamura, T., & Fujita, S. (1981) · Acta Neuropathologica · doi:10.1007/bf00688024 · Cited by 48
McGeer, E. G., Singh, E. A., & McGeer, P. L. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701000-00005 · Cited by 15
Self-citation
Research works printed but not linked: 3
- McGeer, 1987, Biochemistry and pathology of the basal ganglia, Can. J. Neurol. Sci., 19
- del Rio Hortega, 1932, Microglia, Vol. 2, 483
- Tago, H., McGeer, P.L., Bruce, G. and Hersh, L.B., Distribution of cholineacetyltransferase-containing neurons of the hypothalamus, Brain Res., in press.
Cited by
Sorted by citations
Items 501–600 of 834
The Role of Beta-Adrenergic Receptor Blockers in Alzheimer’s Disease
Lương, K. V. Q., & Nguyễn, L. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513488924 · Cited by 32
A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques
Verbeek, M. M., Otte‐Höller, I., Wesseling, P., Nostrand, W. E. V., Sorg, C., de Waal, R. M. W., & Ruiter, D. J. (1995) · Acta Neuropathologica · doi:10.1007/bf00294811 · Cited by 32
Manocha, G. D., Ghatak, A., Puig, K. L., & Combs, C. K. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666180801111033 · Cited by 30
Innate immunity in Alzheimer’s disease: the relevance of animal models?
Franco-Bocanegra, D., Nicoll, J. A. R., & Boche, D. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1729-4 · Cited by 32
INFLAMMATION AND ALZHEIMER'S DISEASE
Gupta, A., & Pansari, K. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11394.x · Cited by 31
Akiyama, H., Tago, H., Itagaki, S., & McGeer, P. L. (1990) · Acta Neuropathologica · doi:10.1007/bf00296114 · Cited by 31
Self-citationMHC Class II expression by microglia in tetanus toxin–induced experimental epilepsy in the rat
Shaw, J. A. G., Perry, V. H., & Mellanby, J. H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00985.x · Cited by 31
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500102 · Cited by 31
Self-citationNeutrophil to lymphocyte ratio in Alzheimer’s disease: A systematic review and meta-analysis
Mohammadi, A., Mohammadi, M., Almasi‐Dooghaee, M., & Mirmosayyeb, O. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305322 · Cited by 30
Hommet, C., Mondon, K., Camus, V., Ribeiro, M. J., Beaufils, É., Arlicot, N., Corcia, P., Paccalin, M., Minier, F., Gosselin, T., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000354363 · Cited by 36
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 30
Amyloid β peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells
Ciaramella, A., Sanarico, N., Bizzoni, F., Moro, M. L., Salani, F., Scapigliati, G., Spalletta, G., Caltagirone, C., & Bossù, P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.007 · Cited by 29
Zesiewicz, T. A., Baker, M. J., Dunne, P. B., & Hauser, R. A. (2001) · Current Treatment Options in Neurology · doi:10.1007/s11940-001-0013-x · Cited by 30
Diesel exhaust impairs TREM2 to dysregulate neuroinflammation
Greve, H. J., Mumaw, C. L., Messenger, E. J., Kodavanti, P. R. S., Royland, J. L., Kodavanti, U. P., & Block, M. L. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02017-7 · Cited by 30
Suppression of Aβ-induced monocyte neurotoxicity by antiinflammatory compounds
Dzenko, K. A., Weltzien, R. B., & Pachter, J. S. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00128-8 · Cited by 29
Neuro-regeneration Therapeutic for Alzheimer’s Dementia: Perspectives on Neurotrophic Activity
Sun, M., & Alkon, D. L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.008 · Cited by 31
A Dichotomous Role for FABP7 in Sleep and Alzheimer’s Disease Pathogenesis: A Hypothesis
Needham, H., Torpey, G., Flores, C. C., Davis, C. J., Vanderheyden, W. M., & Gerstner, J. R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.798994 · Cited by 29
Iulita, M. F., Caraci, F., & Cuello, A. C. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160321104916 · Cited by 28
Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease
Li, X., Tsolis, K. C., Koper, M. J., Ronisz, A., Ospitalieri, S., von Arnim, C. A. F., Vandenberghe, R., Tousseyn, T., Scheuerle, A., Economou, A., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12345 · Cited by 27
Alzheimer's Disease and the “Valley of Death”: Not Enough Guidance from Human Brain Tissue?
Beach, T. G. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129020 · Cited by 28
Implication of matrix metalloproteinases in regulating neuronal disorder
Mukherjee, A. K., & Swarnakar, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3752-y · Cited by 27
Mutti, V., Carini, G., Filippini, A., Castrezzati, S., Giugno, L., Gennarelli, M., & Russo, I. (2023) · Cells · doi:10.3390/cells12131799 · Cited by 28
Alzheimer’s Disease Research Using Human Microglia
Lue, L., Beach, T. G., & Walker, D. G. (2019) · Cells · doi:10.3390/cells8080838 · Cited by 29
Mishra, A., Shang, Y., Wang, Y., Bacon, E. R., Yin, F., & Brinton, R. D. (2020) · iScience · doi:10.1016/j.isci.2020.101829 · Cited by 26
Let’s make microglia great again in neurodegenerative disorders
Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26
Stuart, K. E., King, A. E., King, N. E., Collins, J. M., Vickers, J. C., & Ziebell, J. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.015 · Cited by 27
Rozemüller, A. J. M., Bots, G. T. A. M., Roos, R. A. C., & Eikelenboom, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90087-n · Cited by 27
Qiu, W. Q. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.024 · Cited by 25
Knowledge gaps in Alzheimer's disease immune biomarker research
Morgan, D., & Mielke, M. M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12342 · Cited by 26
Small Molecule Inhibition of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4)
Genung, N. E., & Guckian, K. M. (2017) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2016.11.004 · Cited by 25
Microglia in Alzheimer’s Disease
Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 26
Blockade of chloride intracellular ion channel 1 stimulates Aβ phagocytosis
Paradisi, S., Matteucci, A., Fabrizi, C., Denti, M. A., Abeti, R., Breit, S. N., Malchiodi‐Albedi, F., & Mazzanti, M. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21693 · Cited by 25
Bialowas‐McGoey, L. A., Lesicka, A., & Whitaker‐Azmitia, P. M. (2008) · Glia · doi:10.1002/glia.20727 · Cited by 25
Complements, microglial cells and amyloid fibril formation
Ishii, T., & Haga, S. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80043-k · Cited by 25
Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain
Streit, W. J., Xue, Q., Braak, H., & Tredici, K. D. (2013) · Glia · doi:10.1002/glia.22589 · Cited by 24
Zhang, R., He, Z., Jin, W., & Wang, R. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.07.030 · Cited by 25
Alpha‐tocopherol (vitamin E) induces rapid, nonsustained proliferation in cultured rat microglia
Flanary, B. E., & Streit, W. J. (2006) · Glia · doi:10.1002/glia.20313 · Cited by 24
Chapter 15 MHC antigen expression in spontaneous and induced rejection of neural xenografts
Pollack, I. F., Lund, R. D., & Rao, K. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)62598-4 · Cited by 24
Qin, T., Prins, S., Groeneveld, G. J., van Westen, G. J. P., de Vries, H. E., Wong, Y. C., Bischoff, L. J. M., & de Lange, E. C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093158 · Cited by 24
Molina‐Martínez, P., Corpas, R., García-Lara, E., Cosín‐Tomás, M., Cristòfol, R. M., Kaliman, P., Solà, C., Molinuevo, J. L., Sánchez‐Valle, R., Antonell, A., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.622360 · Cited by 24
Edler, M. K., Munger, E. L., Maycon, H., Hopkins, W. D., Hof, P. R., Sherwood, C. C., & Raghanti, M. A. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25167 · Cited by 23
Woster, A. P., & Combs, C. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04706.x · Cited by 23
Judith Miklossy, A., Qing, H., Guo, J.-P., Yu, S. Y., Wszołek, Z. K., Calne, D. B., McGeer, E. G., & McGeer, P. L. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0230-9 · Cited by 23
Self-citationIntrathecal Release of Nitric Oxide in Alzheimer’s Disease and Vascular Dementia
Tarkowski, E., Ringqvist, Å., Blennow, K., Wallin, A., & Wennmalm, Å. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017261 · Cited by 23
Pinocytosis as a select marker of ramified microglia in vivo and in vitro.
Ranson, P. A., & Thomas, W. E. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.6.2033242 · Cited by 23
Immune Responses in Brains of Alzheimer's and Parkinson's Disease Patients: Hypothesis and Reality
McRae‐Degueurce, A., & Dahlström, A. B. (1992) · Reviews in the Neurosciences · doi:10.1515/revneuro.1992.3.2.79 · Cited by 23
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia
Eisenmenger, L. B., Huo, E. J., Hoffman, J. M., Minoshima, S., Matesan, M. C., Lewis, D. H., Lopresti, B. J., Mathis, C. A., Okonkwo, D. O., & Mountz, J. M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.003 · Cited by 21
Enogieru, A. B., & Momodu, O. I. (2021) · The Botanical Review · doi:10.1007/s12229-021-09246-2 · Cited by 23
Network medicine in drug design: implications for neuroinflammation
Ghosh, S., & Basu, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.018 · Cited by 22
Choi, D., Koppula, S., Choi, M., & Suk, K. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.525220 · Cited by 22
Hashioka, S., Miklossy, J., Schwab, C., Klegeris, A., & McGeer, P. L. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14309 · Cited by 21
Self-citationA Possible Model of Senile Plaques Using Synthetic Amyloid β-Protein and Rat Glial Culture
Isobe, I., Yanagisawa, K., & Michikawa, M. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7316 · Cited by 22
Immunological Markers and Neuropathological Lesions in Alzheimer’s Disease
Pouplard-Barthelaix, A. (1988) · Springer eBooks · doi:10.1007/978-3-642-46634-2_2 · Cited by 22
Zinc utilization by microglia in Alzheimer’s disease
Shippy, D. C., Oliai, S. F., & Ulland, T. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107306 · Cited by 25
Persistent infections, immune-senescence and Alzheimer's disease
Licastro, F., & Porcellini, E. (2016) · Oncoscience · doi:10.18632/oncoscience.309 · Cited by 21
Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders
Miller, S., & Blanco, M.-J. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00036e · Cited by 21
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 24
Marsland, P., Vore, A. S., DaPrano, E. M., Paluch, J. M., Blackwell, A. A., Varlinskaya, E. I., & Deak, T. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.08.013 · Cited by 19
Insufficient Resolution Response in the Hippocampus of a Senescence-Accelerated Mouse Model — SAMP8
Wang, X., Puerta, E., Cedazo-Mı́nguez, Á., Hjorth, E., & Schultzberg, M. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0346-z · Cited by 21
Periodontal Pathogens and Neuropsychiatric Health
Wadhawan, A., Reynolds, M. A., Makkar, H., Scott, A. J., Potocki, E., Hoisington, A. J., Brenner, L. A., Dagdag, A., Lowry, C. A., Dwivedi, Y., et al. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200110161105 · Cited by 22
Neurochemical imaging of dementias
Minoshima, S., Frey, K. A., Cross, D. J., & Kuhl, D. E. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2003.09.008 · Cited by 20
Evidence that neurofibrillary tangles undergo glial modification
Ikeda, K., Akiyama, H., Haga, C., & Haga, S. (1992) · Acta Neuropathologica · doi:10.1007/bf00304639 · Cited by 21
Inflammatory Markers in Chronic Neurodegenerative Disorders with Emphasis on Alzheimer’s Disease
Walker, D. G. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-473-3_2 · Cited by 21
Inflammatory Mediators in Alzheimer’s Disease
Rogers, J., & O’Barr, S. A. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_11 · Cited by 19
Do Microglia default on network maintenance in Alzheimer's disease?
Southam, K. A., Vincent, A. J., & Small, D. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151075 · Cited by 20
Chang, Y.-J., Ho, T.-Y., Wu, M.-L., Hwang, S., Chiou, T., & Tsai, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076118 · Cited by 20
Li, H., Chen, W., Gou, M., Li, W., Tong, J., Zhou, Y., Xie, T., Yu, T. Y., Feng, W., Li, Y., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.966657 · Cited by 21
Reprint of: Microglial toll-like receptors and Alzheimer’s disease
Su, F., Bai, F., Zhou, H., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.016 · Cited by 19
Grotegut, P., Kuehn, S., Meißner, W., Dick, H. B., & Joachim, S. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01786-4 · Cited by 20
Park, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 19
Kım, G., Bolbolan, K., Gefen, T. D., Weıntraub, S., Bigio, E. H., Rogalski, E. J., Mesulam, M. M., & Geula, C. (2018) · Annals of Neurology · doi:10.1002/ana.25240 · Cited by 19
Ohm, D. T., Kım, G., Gefen, T. D., RADEMAKER, A. W., Weıntraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. J., & Geula, C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12494 · Cited by 19
Protective Role of Microglia on Neuronal Survival after Exposure to Amyloid Beta
Lee, S., & Choi, W. (2022) · Chonnam Medical Journal · doi:10.4068/cmj.2022.58.1.13 · Cited by 19
Syed, H., Ikram, M. F., Yaqinuddin, A., & Ahmed, T. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4351 · Cited by 19
Pallebage‐Gamarallage, M. M., Takechi, R., Lam, V., Elahy, M., & Mamo, J. C. L. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1115820 · Cited by 20
Harnessing the immune system for the treatment of Parkinson’s disease
Vedam‐Mai, V. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147308 · Cited by 20
Luckey, A. M., Robertson, I. H., LAWLOR, B. A., Mohan, A., & Vanneste, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210404 · Cited by 24
Geppert, A. M., Losy, J., Przedpelska-Ober, E., & Kozubski, W. P. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.007 · Cited by 19
Dickson, D. W., & Yen, S.-H. C. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90075-4 · Cited by 19
Smits, H. A., Vos, N., Wat, J. W. Y., van der Bruggen, T., Verhoef, J., & Nottet, H. S. L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00254-5 · Cited by 23
Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia
Dahlström, A. B., McRae‐Degueurce, A., Polinsky, R. J., Nee, L. E., Sadasivan, B., & Ling, E. A. (1994) · Molecular Neurobiology · doi:10.1007/bf02816104 · Cited by 19
Walker, D. G., Itagaki, S., Berry, K., & McGeer, P. L. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.5.583 · Cited by 19
Self-citationAlzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
Ajit, D., Udan, M. L. D., Paranjape, G. S., & Nichols, M. R. (2009) · Biochemistry · doi:10.1021/bi9003777 · Cited by 18
Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer’s Disease Patients
Ju, T., Sun, L., Fan, Y., Wang, T., Liu, Y., Liu, D., Liu, T., Zhao, C. W., Wang, W., & Chi, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.762649 · Cited by 18
COVID‐19 and the impact on Alzheimer's disease pathology
Furman, S., Green, K. N., & Lane, T. E. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15985 · Cited by 18
Khorshid, H. R. K., Manoochehri, M., Nasehi, L., Ohadi, M., Rahgozar, M., & Kamali, K. (2012) · Europe PMC (PubMed Central) · Cited by 19
Jorge, L., Martins, R., Canário, N., Xavier, A. C., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200840 · Cited by 19
Hamaguchi, A., Tooyama, I., Yoshiki, T., & Kimurâ, H. (1995) · The Prostate · doi:10.1002/pros.2990270304 · Cited by 18
Early complement activation increases in the brain in some aged normal subjects
Loeffler, D. A., Camp, D. M., Schonberger, M. B., Singer, D. J., & LeWitt, P. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.003 · Cited by 18
Expression of CD43 in human microglia and its downregulation in Alzheimer's disease
Matsuo, A., Walker, D. G., Terai, K., & McGeer, P. L. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00134-8 · Cited by 18
Self-citationPolinsky, R. J., McRae‐Degueurce, A., Baser, S. M., & Dahlström, A. B. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90201-h · Cited by 18
McRae‐Degueurce, A., Dahlström, A. B., Polinsky, R. J., & Ling, E. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90139-h · Cited by 18
Guo, F., Sheng, Z.-H., Fu, Y., Wang, Z., Xue, R., Tan, M., Tan, M.-S., & Wang, Z.-T. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03458-5 · Cited by 21
Tolédano, A., Rodríguez‐Casado, A., Álvarez, M., & Toledano‐Díaz, A. (2024) · Brain Sciences · doi:10.3390/brainsci14111101 · Cited by 19
Tambini, M. D., & D'adamio, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-60800-1 · Cited by 16
Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis
Manocha, G. D., Puig, K. L., Austin, S. A., Seyb, K. I., Glicksman, M. A., & Combs, C. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132604 · Cited by 17
Neuroinflammation and Alzheimer’s Disease
Eikelenboom, P. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5405-9_3 · Cited by 17
Hu, G., Walls, R. S., Creasey, H. M., McCusker, E. A., & Broe, G. A. (1995) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1995.tb01525.x · Cited by 17
Lu, J., Kaur, C., & Ling, E. (1994) · PubMed · Cited by 17
Metadata
- Authors
- McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McGeer, Patrick L.
- ORCID
- McGeer, Patrick L.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 1987-08
- Volume
- 79
- Issue
- 1-2
- Pages
- 195-200
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2074274825
- Cited by
- 836
- References
- 9
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 24 · 2023: 36 · 2022: 32 · 2021: 30 · 2020: 40 · 2019: 31 · 2018: 26 · 2017: 28 · 2016: 21 · 2015: 27 · 2014: 34 · 2013: 27 · 2012: 27
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- reactive microglia, HLA-DR, senile dementia of the Alzheimer type, Alzheimer's disease, amyloid plaques, glial fibrillary acidic protein, astrocytes, choline acetyltransferase, hippocampus, neuroinflammation
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cerebral Cortex, Hippocampus, HLA-D Antigens, HLA-DR Antigens, Humans, Neuroglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review